Disorders
Study Notes on Behavioral Health Disorders, Treatments, Therapies & Services
Overview
This study guide is designed for the HOSA SQE Behavioral Health Exam, covering various mental health disorders, their definitions, causes, symptoms, treatments, and professional involvements based on CDC, NIMH, and SAMHSA sources.
General Topics
Major Disorders
Treatments and Therapies
Key Professionals Involved
Diagnostic Codes (DSM-5 and ICD-10)
Symptoms and Co-occurring Conditions
Autism Spectrum Disorder (ASD)
Definition
ASD: A neurodevelopmental disorder characterized by:
Persistent deficits in social communication and social interaction
Restricted, repetitive patterns of behavior, interests, or activities
Symptoms typically develop in early childhood but may be recognized later.
Spectrum: Variation exists in severity, abilities, and support needs.
Causes & Risk Factors
Genetic Factors
Strong heritability
Increased likelihood with siblings who have ASD
Associated conditions: Fragile X syndrome, among others.
Environmental Factors
Advanced parental age
Low birth weight or prematurity
Pregnancy complications
Prenatal exposures (e.g., valproic acid)
Vaccination: No evidence links vaccines to autism. (CDC)
Brain Development Differences
Early brain overgrowth
Atypical neural connectivity affecting social communication areas.
Core Symptoms
Social Communication Deficits
Reduced eye contact
Difficulty understanding social cues
Challenges in conversation and relationships
Repetitive & Restricted Behaviors
Repetitive movements (e.g., hand flapping)
Insistence on routines
Sensory processing differences
Co-occurring Conditions
ADHD
Anxiety disorders
Depression
Intellectual disabilities (in some instances)
Epilepsy/seizure disorders
GI problems
Sleep disturbances
Screening & Diagnosis
Diagnostic Tools:
M-CHAT-R/F (Modified Checklist for Autism in Toddlers)
ASQ (Ages and Stages Questionnaire)
Professionals Diagnosing:
Developmental pediatricians, child psychologists, psychiatrists, neurologists, clinical psychologists.
DSM-5 Category & Codes
Category: Neurodevelopmental Disorders
DSM-5 Code: 299.00
ICD-10 Code: F84.0
Severity Levels:
Level 1: Requiring support
Level 2: Requiring substantial support
Level 3: Requires very substantial support.
Treatment (Evidence-Based)
Behavioral & Developmental Interventions
Applied Behavior Analysis (ABA): Gold standard of therapy.
Early Start Denver Model (ESDM): For toddlers.
Speech-language therapy, occupational therapy, social skills training.
Educational Services
Individualized Education Programs (IEPs).
Special education supports.
Medications: Address irritability, anxiety, ADHD symptoms.
IRRITABILITY: Risperidone, Aripiprazole.
Family Support Services
Parent training programs, respite services, case management.
Professionals Involved in Treatment
Child psychologists, developmental pediatricians, psychiatrists, neurologists, therapy support staff, education professionals.
Key roles: ABA therapists, speech-language pathologists, occupational therapists, special education teachers, and social workers.
Key Facts for SQE
ASD is diagnosed based on DSM-5 criteria.
Early intervention is crucial for improving outcomes.
ABA is widely utilized and evidence-based.
Vaccines do not cause autism.
Attention-Deficit/Hyperactivity Disorder (ADHD)
Definition
ADHD: A neurodevelopmental disorder characterized by:
Patterns of inattention and/or hyperactivity-impulsivity affecting functioning.
Symptoms must be present before age 12 and occur in multiple settings (home, school, etc.).
Types (DSM-5 Presentations)
Predominantly Inattentive Presentation
Predominantly Hyperactive-Impulsive Presentation
Combined Presentation
Causes & Risk Factors
Genetic Factors
High heritability; first-degree relatives increase risk.
Brain Development Differences:
Related to attention, impulse control, and executive functioning networks.
Environmental Risk Factors:
Prenatal exposure to toxins (e.g., alcohol, tobacco).
Low birth weight and brain injury (less common).
Core Symptoms
Inattention
Difficulty maintaining attention
Careless mistakes and forgetfulness
Easily distracted.
Hyperactivity:
Fidgeting and excessive movement
Difficulty remaining seated
“On the go” behavior.
Impulsivity:
Interrupting others
Difficulty waiting for one's turn.
Co-Occurring Conditions
Learning disabilities
Anxiety disorders
Depression
Substance use disorders in adolescence/adulthood.
Diagnosis
ADHD diagnosis involves:
Clinical interviews, symptom checklists, behavioral observations, report collection from parents/teachers.
Professionals: Psychiatrists, psychologists, pediatricians.
DSM-5 Category & Codes
Category: Neurodevelopmental Disorders
DSM-5 Codes: 314.00 (Inattentive) / 314.01 (Combined)
ICD-10 Codes: F90.0-F90.9
Treatment (Evidence-Based & Highly Testable)
Medications
Stimulants (first-line): Methylphenidate, Amphetamines.
Non-Stimulants: Atomoxetine, Guanfacine, Clonidine.
Behavioral Therapy
Primarily for children under 12.
Parent training in behavior management, behavior modification programs, difficult to manage tasks.
School/Educational Support
Accommodations like IEPs/504 Plans.
Psychotherapy:
CBT for emotional regulation.
Social skills training.
Family & Community Support
Case management, family education, peer support.
Professionals Involved
Diagnosis & Medication: Psychiatrists, psychologists; Pediatricians; Nurse practitioners.
Behavioral Treatment: Psychologists, therapists, school counselors, special education teachers.
Consequences if Untreated
Academic difficulties, behavioral issues, substance misuse, impaired relationships.
Key Facts Likely on SQE
Symptoms must start before age 12.
Diagnosis utilizes DSM-5 criteria, not blood tests or scans.
Stimulants are the most effective treatments, with CBT essential for young children.
Schizophrenia
Definition
Schizophrenia: A chronic, severe mental disorder affecting:
Thinking, perception, emotions, and behavior.
Involves psychosis, impairing reality distinction.
Symptoms often begin in late adolescence or early adulthood.
Causes & Risk Factors
Genetic Factors
Strong hereditary link; higher risk with a family history.
Brain Structure & Chemistry Differences
Abnormalities in dopamine pathways.
Differences in brain volume and cortical thickness.
Environmental Factors
Complications at birth, prenatal malnutrition, stress, substance use (cannabis).
Core Symptoms (DSM-5)
Diagnosis requires two or more symptoms for at least 1 month:
Positive Symptoms
Hallucinations (often auditory)
Delusions (firm false beliefs)
Disorganized speech/behavior.
Negative Symptoms
Flat affect, reduced speech, lack of motivation, social withdrawal.
Cognitive Symptoms
Impairments in executive functioning, focusing, and working memory.
Related Psychotic Disorders
Schizoaffective disorder, Schizophreniform disorder, Brief psychotic disorder.
DSM-5 Category & Codes
Category: Schizophrenia Spectrum and Other Psychotic Disorders
DSM-5 Code: 295.90
ICD-10 Code: F20.9
Diagnosis
Conducted by licensed mental health professionals, including psychiatric evaluations and symptom reviews.
Treatment
Antipsychotic Medications (first-line):
Typical: Haloperidol, Chlorpromazine.
Atypical: Risperidone, Clozapine (monitoring required).
Psychosocial Treatments:
CBT for psychosis (CBTp), social skills training, family psychoeducation, case management.
Hospitalizations: For crisis stabilization and safety measures.
Professionals Involved
Treatment: Psychiatrists, psychiatric nurse practitioners, primary care providers, therapy professionals.
Complications if Untreated
Worsening symptoms, functional decline, homelessness, high relapse risk, increased suicide risk.
Key Facts Likely on SQE
Auditory hallucinations are common; diagnosis requires symptoms lasting at least six months.
Bipolar Disorder
Definition
Bipolar Disorder: A chronic mood disorder that involves:
Cycles of manic or hypomanic and depressive episodes.
Types of Bipolar Disorder (DSM-5)
Bipolar I Disorder: At least one full manic episode (depressive episodes not required).
Bipolar II Disorder: At least one hypomanic episode and one major depressive episode.
Cyclothymic Disorder: Chronic mood disturbances lasting 2+ years, with periods not meeting full criteria for episodes.
Episode Definitions
Manic Episode: Lasts 1 week, requires elevated mood & additional symptoms (e.g., grandiosity, decreased sleep).
Hypomanic Episode: Similar to mania, but less severe and not requiring hospitalization.
Major Depressive Episode: Persistent low mood, loss of interest for 2+ weeks.
Causes & Risk Factors
Biological & Genetic Factors: Strong heritability; brain structure differences in emotion regulation circuits.
Environmental Factors: Stressful life events, trauma, substance use.
Signs & Symptoms
Mania/Hypomania: Elevated mood; decreased sleep; risky behavior.
Depression Symptoms: Feelings of hopelessness, fatigue, suicidal thoughts.
Co-occurring Conditions
Anxiety disorders, ADHD, substance use disorders, eating disorders.
DSM-5 Category & Codes
Category: Bipolar and Related Disorders
Bipolar I: 296.40–296.44
Bipolar II: 296.89
Cyclothymic Disorder: 301.13
ICD-10 Codes: F31.0–F31.9.
Diagnosis
Conducted by mental health professionals using DSM-5 criteria, clinical interviews, mood charting, and thorough history.
Treatment
Mood Stabilizers (first-line): Lithium (reduces suicide risk); Valproate.
Atypical Antipsychotics: For manic episodes.
Psychotherapy: CBT, family-focused therapy, lifestyle support.
Professionals Involved
Medication: Psychiatrists, nurse practitioners.
Therapeutic Support: Psychologists, social workers, peer specialists, crisis treatment teams.
Key Facts Likely to Appear on SQE
Bipolar I requires a manic episode, while Bipolar II requires at least one major depressive episode.
Depression (Major Depressive Disorder & Related Disorders)
Definition
Depression: A serious mood disorder negatively affecting thoughts, emotions, and actions, with symptoms lasting 2+ weeks.
Types of Depressive Disorders (DSM-5)
Major Depressive Disorder (MDD): Significant impairment for at least 2 weeks.
Persistent Depressive Disorder (Dysthymia): Chronic depression for 2+ years.
Seasonal Affective Disorder (SAD): Seasonal depression.
Causes & Risk Factors
Biological Factors: Genetic predisposition, brain chemistry imbalances.
Environmental Factors: Stress, trauma, major life changes.
Other Risk Factors: History of depression, substance misuse, chronic illness.
Core Symptoms (DSM-5)
Emotional: Depressed mood, anhedonia, worthlessness.
Physical: Changes in sleep/appetite, fatigue.
Cognitive: Trouble concentrating, suicidal thoughts.
Co-occurring Conditions
Anxiety disorders, PTSD, substance use disorders, chronic medical conditions.
DSM-5 Category & Codes
Major Depressive Disorder: 296.20–296.36.
ICD-10 Codes: F32 (single episode), F33 (recurrent).
Diagnosis
Diagnosis conducted by licensed professionals, considering questionnaires (PHQ-9) and rule-out of medical conditions.
Treatment
Psychotherapy (Highly Testable):
Cognitive Behavioral Therapy (CBT): Gold standard for reframing negative patterns.
Interpersonal Therapy (IPT)
Behavioral Activation: Engagement in positive activities.
Medications: Antidepressants (SSRIs, SNRIs).
Must be taken consistently; may take 4-6 weeks for effect.
Severe Cases: ECT for severe treatment-resistant cases.
Professionals Involved
Medical Management: Psychiatrists, nurse practitioners.
Therapeutic Support: Psychologists, licensed counselors, social workers.
Key Facts Likely to Appear on SQE
Symptoms must last 2+ weeks for MDD.
SSRIs are first-line treatments.
Anxiety Disorders
Definition
Anxiety Disorders: Excessive fear or worry that interrupts daily function; the most common mental health disorders in the U.S.
Common Types (DSM-5)
Generalized Anxiety Disorder (GAD): Chronic, excessive worry for at least 6 months.
Panic Disorder: Recurrent, unexpected panic attacks.
Social Anxiety Disorder: Intense fear of social situations.
Specific Phobias: Intense fear of specific objects.
Agoraphobia: Fear of situations where escape might be difficult.
Separation Anxiety Disorder: Common in children.
Causes & Risk Factors
Genetic & Biological Factors: Family history of anxiety disorders, neurotransmitter dysregulation.
Environmental & Psychological Factors: Trauma, chronic stress, medical illness, or substance misuse.
Symptoms
Physical: Palpitations, shortness of breath.
Cognitive: Excessive worry, difficulty concentrating.
Behavioral: Avoidance of feared situations, restlessness.
Co-occurring Conditions
Depression, substance use disorders, PTSD, OCD.
DSM-5 Category & Codes
Generalized Anxiety Disorder: 300.02
Panic Disorder: 300.01
Social Anxiety Disorder: 300.23
ICD-10: F40–F41.
Diagnosis
Diagnosed by professionals using clinical interviews, symptom questionnaires (GAD-7), and rule-out of medical causes.
Treatment
Psychotherapy (first-line):
Cognitive Behavioral Therapy (CBT): Gold standard for anxiety.
Medications: SSRIs, SNRIs; benzodiazepines used for short-term management.
Lifestyle Adjustments: Stress reduction, exercise, sleep hygiene.
Professionals Involved
Medical: Psychiatrists, primary care providers.
Therapy: Psychologists, licensed counselors.
Community & Crisis Support: Peer support specialists, crisis teams.
Key Facts Likely to Appear on SQE
High prevalence and treatability of anxiety disorders.
CBT and SSRIs/SNRIs considered first-line treatments.
Obsessive-Compulsive Disorder (OCD)
Definition
OCD: Chronic mental health disorder featuring:
Obsessions: Intrusive, unwanted thoughts causing distress.
Compulsions: Repetitive behaviors performed to alleviate anxiety.
Causes & Risk Factors
Biological Factors: Neurotransmitter dysregulation; genetic predisposition.
Environmental Factors: Trauma, chronic stress, childhood abuse.
Symptoms
Obsessions: Fear of contamination, harming others, needing symmetry.
Compulsions: Hand washing, checking, counting rituals.
Co-occurring Conditions
Anxiety disorders, depression, tic disorders.
DSM-5 Category & Codes
OCD: 300.3
ICD-10 Code: F42.
Diagnosis
Conducted by mental health professionals using symptom checklists and clinical interviews.
Treatment
Psychotherapy:
Cognitive Behavioral Therapy (CBT): Gold standard, especially with exposure and response prevention.
Medications: SSRIs (fluoxetine, fluvoxamine) as first-line treatments.
Professionals Involved
Psychiatrists, social workers, and therapists for comprehensive treatment approaches.
Key Facts Likely to Appear on SQE
OCD is time-consuming and involves compulsions designed to reduce anxiety. CBT with ERP is the most effective psychotherapy.
Post-Traumatic Stress Disorder (PTSD)
Definition
PTSD: A disorder that may develop after exposure to a traumatic event, characterized by:
Intrusive memories, avoidance, negative cognition, arousal symptoms persist for more than 1 month.
Causes & Risk Factors
Exact Trauma Exposure: Military combat, sexual assault, natural disasters.
Individual Vulnerability: Previous trauma, genetic predisposition, lack of social support.
Symptoms (DSM-5 Criteria)
Intrusion: Flashbacks, nightmares, distressing memories.
Avoidance: Steering clear of reminders of the trauma.
Negative Mood Alterations: Persistent negative beliefs, detachment.
Altered Arousal & Reactivity: Hypervigilance, irritability.
Co-occurring Conditions
Depression, anxiety disorders, substance use disorders.
DSM-5 Category & Codes
PTSD: 309.81
ICD-10 Code: F43.10.
Diagnosis
Diagnosed by clinical interviews, trauma history assessments, using standardized tools.
Treatment
Psychotherapy:
Trauma-Focused CBT, Prolonged Exposure Therapy, EMDR as effective treatments.
Medications: SSRIs as first-line pharmacotherapy.
Key Facts Likely to Appear on SQE
Core PTSD clusters include intrusive memories and changes in mood. Trauma-focused CBT is a primary treatment method.
Personality Disorders (PDs)
Definition
PDs: Enduring patterns of behavior affecting various domains, often deviating from cultural norms, leading to distress and impairment.
Causes & Risk Factors
Biological & Genetic Factors: Heritability varies across different disorders.
Environmental Factors: Childhood trauma, inconsistent parenting, and attachment issues also play roles.
Clinical Categories (DSM-5 Clusters)
Cluster A: Odd, eccentric behavior (e.g., Paranoid, Schizoid).
Cluster B: Dramatic, emotional behavior (e.g., Antisocial, Borderline).
Cluster C: Anxious, fearful behavior (e.g., Avoidant, Dependent).
Diagnosis
Conducted by mental health professionals considering behavioral patterns and functioning impact.
Treatment
Psychotherapy:
DBT for Borderline PD, CBT for maladaptive thinking.
Medications: To manage specific symptoms, but no direct treatments for PDs.
Key Facts Likely to Appear on SQE
Personality disorders evolve from complex interactions between genetic and environmental influences, entail lifelong issues requiring comprehensive management strategies.
Dissociative Disorders
Definition
Dissociative Disorders: Disorders involving disruptions in consciousness, memory, and identity often caused by severe trauma or stress.
Types of Dissociative Disorders (DSM-5)
Dissociative Identity Disorder (DID): Two or more distinct identities.
Dissociative Amnesia: Inability to recall information about oneself.
Depersonalization/Derealization Disorder: Feelings of detachment from self or surroundings.
Treatment
Psychotherapy:
Trauma-focused CBT, DBT, EMDR for DID.
Community and Peer Support: Case management, support groups.
Key Facts Likely to Appear on SQE
Dissociative disorders are typically trauma-related and do not stem from neurological foundations.